Healthcare & Life Sciences
Promentis Pharmaceuticals, Inc
United Statespromentispharma.com
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Promentis Pharmaceuticals, Inc. is a biopharmaceutical company developing novel oral therapies targeting neuropsychiatric disorders such as trichotillomania by modulating glutamate signaling in the brain.
Explore Promentis Pharmaceuticals, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.